Intas has signed an exclusive agreement with SII-backed IntegriMedical to deploy needle-free injection systems across IVF ...

Intas collaborates with IntegriMedical to launch India’s first needle-free injection system for IVF and gynaecology: Our ...

Intas Pharmaceuticals has partnered with IntegriMedical to launch India's first needle-free injection system for IVF and gynecology treatments. This initiative aims to transform patient care by ...

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

The Needle-Free Injection System Market represents a groundbreaking advancement in medical technology, offering an innovative alternative to traditional needle-based drug delivery methods. These ...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company who has developed and commercialized an intradermal needle-free platform to more effectively administer drugs and biologics, today announced that ...

First self-administered, needle-free injection system approved by Health Canada gives access to safe, painless, cost-effective, and more sustainable drug delivery for chronic illnesses Toronto, ...

Expected Revenue Growth. What This Report Will Provide? Target Audience. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, ...

Research and Markets has announced the addition of the "Needle-Free Drug Injection Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive ...

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth ...

Intas Pharmaceuticals on Monday said it has tied up with IntegriMedical to introduce a needle free injection system for use in IVF and gynecology treatments. As part of the agreement, Intas has become ...

The PharmaJet Tropis Intradermal (ID) Needle-free System will be used exclusively to deliver vaccine to 1.8 million children in upcoming campaign. To date, 12+ million pediatric injections have been ...